Ninety One UK Ltd Boosts Holdings in Danaher Co. (NYSE:DHR)

Ninety One UK Ltd raised its holdings in Danaher Co. (NYSE:DHR) by 3.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 134,189 shares of the conglomerate’s stock after purchasing an additional 4,434 shares during the period. Ninety One UK Ltd’s holdings in Danaher were worth $30,803,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of DHR. AMF Tjanstepension AB purchased a new position in shares of Danaher in the third quarter worth about $5,923,000. Czech National Bank grew its stake in Danaher by 4.2% during the third quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after acquiring an additional 5,320 shares in the last quarter. Diversified Trust Co grew its stake in Danaher by 29.6% during the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock valued at $1,571,000 after acquiring an additional 1,289 shares in the last quarter. Miracle Mile Advisors LLC purchased a new position in Danaher during the third quarter valued at approximately $310,000. Finally, Mather Group LLC. grew its stake in Danaher by 9.2% during the third quarter. Mather Group LLC. now owns 8,931 shares of the conglomerate’s stock valued at $2,483,000 after acquiring an additional 749 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on DHR shares. KeyCorp lifted their target price on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Scotiabank started coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Stephens reiterated an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Robert W. Baird lowered their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 10.90% of the company’s stock.

Danaher Stock Down 1.4 %

Shares of Danaher stock opened at $211.92 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company’s fifty day simple moving average is $234.50 and its two-hundred day simple moving average is $252.68. The company has a market cap of $153.07 billion, a P/E ratio of 40.14, a PEG ratio of 2.80 and a beta of 0.83. Danaher Co. has a 12-month low of $210.04 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm posted $2.09 EPS. Research analysts anticipate that Danaher Co. will post 7.77 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.